Freenome, headquartered in South San Francisco, is focused on developing a diagnostic test for early detection of cancer and other diseases on the so-called "liquid biopsy," in other words, blood.…

The agreement validates Teva’s IP and resolves Alder’s opposition to Teva’s European Patent No. 1957106 B1. Source: BioSpace

Rumors that Acorda was considering a sale drove company stock up about 12 percent on Friday, Jan. 5, to hit $23.55. Source: BioSpace

Alder intends to use the cash to fund payments under Alder’s European patent settlement and global license agreement with Teva announced today. Source: BioSpace

The offers underline Novo Nordisk's interest in expanding beyond diabetes and into the rare diseases market. Source: BioSpace

The expense is primarily related to taxes on unremitted offshore earnings, the company said. Source: BioSpace

The two companies struck the deal in 2015. Source: BioSpace

Agreement covers employees who agree to leave voluntarily. Source: BioSpace

Takeda CEO Christophe Weber is sticking to his game plan of actively hunting deals that will expand its global presence and create a stronger international profile. Source: BioSpace

Kala Pharma released mostly positive topline results from two Phase III clinical trials for KPI-121 in patients with dry eye disease. Source: BioSpace